Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

NCT00519064 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

361

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Disease

Interventions

BIOLOGICAL: Adjuvanted influenza vaccine

Sponsor

Novartis Vaccines